Evidence map›Paper›PMID 41089372›Full record

ArticleOncology letters2025

Anticancer effects of the Kiperin Purple Collagen complex: Evidence from HCT116 and MIA PaCa-2 cell models.

Lutfiye Karcioglu Batur, Cuneyd Yavas, Nezih Hekim

Abstract read
In one paragraph

Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lutfiye Karcioglu BaturDepartment of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Biruni University, Istanbul 34015, Turkey.
Cuneyd YavasDepartment of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Biruni University, Istanbul 34015, Turkey.
Nezih HekimDepartment of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Biruni University, Istanbul 34015, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purple Collagen is a bioactive complex containing double-hydrolyzed collagens (types I, II, III, V and X) and various bioactive components (inulin, elderberry extract, magnesium citrate and malate, eggshell membrane, bromelain, black cumin extract and liposomal vitamin C). These bioactive compounds have attracted increasing scientific interest due to their ability to modulate key cancer-associated pathways, including the inhibition of cell proliferation and migration, suppression of oxidative stress via free radical scavenging and induction of apoptosis through mitochondrial and caspase-dependent mechanisms. While individual components of the Purple Collagen complex (PCC) have been associated with various health benefits, their combined effects on cancer cell behavior remain largely unexplored. The present study investigated the effects of PCC on cell proliferation, migration, oxidative stress and apoptosis in two cancer cell lines: HCT116 (colorectal carcinoma) and MIA PaCa-2 (pancreas carcinoma). The cell viability, migration, oxidative stress [total oxidant status (TOS)/total antioxidant status (TAS)] and apoptotic and cell cycle regulatory markers (

Indexed as

HCT116 colon carcinomahydrolyzed collagenMIA PACA-2 pancreas carcinomaPurple Collagen

Identifiers

PMID41089372
PMCPMC12516481

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.